Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis

被引:17
作者
Zhang, Li Xin [1 ]
Martineau, Patrick [2 ]
Finnerty, Vincent [1 ]
Giraldeau, Genevieve [3 ]
Parent, Marie-Claude [3 ]
Harel, Francois [1 ]
Pelletier-Galarneau, Matthieu [1 ,4 ]
机构
[1] Inst Cardiol Montreal, Dept Med Imaging, Montreal, PQ, Canada
[2] BC Canc Agcy, Vancouver, BC, Canada
[3] Inst Cardiol Montreal, Dept Med, Montreal, PQ, Canada
[4] Harvard Med Sch, Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Boston, MA 02115 USA
关键词
Molecular imaging agents; Diagnostic and prognostic application; Molecular imaging; PET; Amyloid heart disease; DIAGNOSIS; SCINTIGRAPHY;
D O I
10.1007/s12350-020-02425-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Pyrophosphate (PYP) scintigraphy provides high diagnostic accuracy for the detection of transthyretin (ATTR) cardiac amyloidosis (CA). There has recently been emerging interest in using 18F-sodium fluoride (NaF) for this application, yet its sensitivity has never been directly compared to that of PYP, the current molecular gold standard Methods Twelve subjects with ATTR-CA and 5 controls referred for PYP-SPECT were prospectively enrolled. 18F-NaF PET/CT scans were performed at 1 and 3 hours. Qualitative and quantitative analyses of the images were performed, and the sensitivity of 18F-NaF PET/CT and PYP-SPECT were compared Results Visual interpretation of NaF PET/CT yielded a sensitivity of 0.25 (95% CI 0.089 to 0.53) for the detection of ATTR-CA, which is significantly inferior to that of PYP-SPECT/CT (100%, P = .016). Visual interpretation at 3 hours yielded a similar sensitivity of 0.30 (95% CI 0.11 to 0.60, P = 1.00). There were no false-positive NaF PET studies. Mean target-to-background ratio (TBRmean) at 1h did not differ significantly (P = .21) in ATTR-CA subjects (0.83 +/- 0.15) compared to controls (0.72 +/- 0.15). Receiver operating characteristic (ROC) analysis yielded an area under the curve (AUC) of 0.69 +/- 0.16 (95% CI 0.37 to 1.00, P = .23). Conclusion With qualitative and quantitative analyses, sensitivity of NaF PET/CT is significantly inferior to that of PYP-SPECT for the diagnosis of ATTR-CA
引用
收藏
页码:1132 / 1140
页数:9
相关论文
共 27 条
[11]   Cardiac amyloidosis [J].
Martinez-Naharro, Ana ;
Hawkins, Philip N. ;
Fontana, Marianna .
CLINICAL MEDICINE, 2018, 18 (02) :S30-S35
[12]   Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy [J].
Maurer, Mathew S. ;
Schwartz, Jeffrey H. ;
Gundapaneni, Balarama ;
Elliott, Perry M. ;
Merlini, Giampaolo ;
Waddington-Cruz, Marcia ;
Kristen, Arnt V. ;
Grogan, Martha ;
Witteles, Ronald ;
Damy, Thibaud ;
Drachman, Brian M. ;
Shah, Sanjiv J. ;
Hanna, Mazen ;
Judge, Daniel P. ;
Barsdorf, Alexandra I. ;
Huber, Peter ;
Patterson, Terrell A. ;
Riley, Steven ;
Schumacher, Jennifer ;
Stewart, Michelle ;
Sultan, Marla B. ;
Rapezzi, Claudio .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11) :1007-1016
[13]   18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis [J].
Morgenstern, Rachelle ;
Yeh, Randy ;
Castano, Adam ;
Maurer, Mathew S. ;
Bokhari, Sabahat .
JOURNAL OF NUCLEAR CARDIOLOGY, 2018, 25 (05) :1559-1567
[14]   Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis [J].
Ng, Quinn K. T. ;
Sethi, Pooja ;
Saunders, Tara A. ;
Pampaloni, Miguel Hernandez ;
Flavell, Robert R. .
CLINICAL NUCLEAR MEDICINE, 2018, 43 (03) :e89-e92
[15]   Molecular Imaging of Cardiac Amyloidosis [J].
Pelletier-Galarneau, Matthieu ;
Abikhzer, Gad ;
Giraldeau, Genevieve ;
Harel, Francois .
CURRENT CARDIOLOGY REPORTS, 2019, 21 (03)
[16]   Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy [J].
Perugini, E ;
Guidalotti, PL ;
Salvi, F ;
Cooke, RMT ;
Pettinato, C ;
Riva, L ;
Leone, O ;
Farsad, M ;
Ciliberti, P ;
Bacchi-Reggiani, L ;
Fallani, F ;
Branzi, A ;
Rapezzi, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (06) :1076-1084
[17]   Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis [J].
Rapezzi, Claudio ;
Gagliardi, Christian ;
Milandri, Agnese .
JOURNAL OF NUCLEAR CARDIOLOGY, 2019, 26 (05) :1638-1641
[18]   Role of 99mTc-DPD Scintigraphy in Diagnosis and Prognosis of Hereditary Transthyretin-Related Cardiac Amyloidosis [J].
Rapezzi, Claudio ;
Quarta, Candida C. ;
Guidalotti, Pier Luigi ;
Pettinato, Cinzia ;
Fanti, Stefano ;
Leone, Ornella ;
Ferlini, Alessandra ;
Longhi, Simone ;
Lorenzini, Massimiliano ;
Reggiani, Letizia Bacchi ;
Gagliardi, Christian ;
Gallo, Pamela ;
Villani, Caterina ;
Salvi, Fabrizio .
JACC-CARDIOVASCULAR IMAGING, 2011, 4 (06) :659-670
[19]   Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy [J].
Rapezzi, Claudio ;
Quarta, Candida Cristina ;
Guidalotti, Pier Luigi ;
Longhi, Simone ;
Pettinato, Cinzia ;
Leone, Ornella ;
Ferlini, Alessandra ;
Salvi, Fabrizio ;
Gallo, Pamela ;
Gagliardi, Christian ;
Branzi, Angelo .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (03) :470-478
[20]   Systemic Cardiac Amyloidoses Disease Profiles and Clinical Courses of the 3 Main Types [J].
Rapezzi, Claudio ;
Merlini, Giampaolo ;
Quarta, Candida C. ;
Riva, Letizia ;
Longhi, Simone ;
Leone, Ornella ;
Salvi, Fabrizio ;
Ciliberti, Paolo ;
Pastorelli, Francesca ;
Biagini, Elena ;
Coccolo, Fabio ;
Cooke, Robin M. T. ;
Bacchi-Reggiani, Letizia ;
Sangiorgi, Diego ;
Ferlini, Alessandra ;
Cavo, Michele ;
Zamagni, Elena ;
Fonte, Maria Luisa ;
Palladini, Giovanni ;
Salinaro, Francesco ;
Musca, Francesco ;
Obici, Laura ;
Branzi, Angelo ;
Perlini, Stefano .
CIRCULATION, 2009, 120 (13) :1203-1212